Margaret Clagett-Dame - Publications

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
Biochemistry
Website:
https://biochem.wisc.edu/faculty/clagett-dame

89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Plum LA, Zella J, Clagett-Dame M, DeLuca HF. A New 1,25 Dihydroxy Vitamin D Analog with Strong Bone Anabolic Activity in OVX Rats with Little or No Bone Resorptive Activity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31369169 DOI: 10.1002/jbmr.3838  0.96
2018 Anding AL, Jones JD, Newton MA, Curley RW, Clagett-Dame M. 4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L. Anticancer Research. 38: 4403-4416. PMID 30061204 DOI: 10.21873/anticanres.12742  0.76
2017 Ahrens JM, Jones JD, Nieves NJ, Mitzey AM, DeLuca HF, Clagett-Dame M. Differential activity of 2-methylene-19-nor vitamin D analogs on growth factor gene expression in rhino mouse skin and comparison to all-trans retinoic acid. Plos One. 12: e0188887. PMID 29182680 DOI: 10.1371/journal.pone.0188887  0.96
2017 Pandey R, Zella JB, Zhu JG, Plum LA, Clagett-Dame M, Blaser WJ, Bedale W, DeLuca HF, Coyne DW. Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D3) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on Hemodialysis. Drugs in R&D. PMID 28905271 DOI: 10.1007/s40268-017-0210-z  0.96
2016 Cavanaugh KR, Narayanasamy S, Walker JR, Clagett-Dame M, Curley RW. Improved Synthesis of the C-Glucuronide/Glycoside of 4-Hydroxybenzylretinone (4-HBR). Journal of Carbohydrate Chemistry. 35: 249-260. PMID 28626297 DOI: 10.1080/07328303.2016.1227831  0.76
2016 Thadhani R, Zella JB, Knutson DC, Blaser WJ, Plum LA, Clagett-Dame M, Buck RD, DeLuca HF. 2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial. American Journal of Nephrology. 45: 40-48. PMID 27880946 DOI: 10.1159/000452680  1
2016 Pandey R, Zella J, Clagett-Dame M, Plum LA, DeLuca HF, Coyne DW. Use of 2MD, a Novel Oral Calcitriol Analog, in Hemodialysis Patients with Secondary Hyperparathyroidism. American Journal of Nephrology. 43: 213-220. PMID 27096733 DOI: 10.1159/000445756  1
2016 Knutson DC, Mitzey AM, Talton LE, Clagett-Dame M. Mice null for NEDD9 (HEF1) display extensive hippocampal dendritic spine loss and cognitive impairment. Brain Research. 1632: 141-55. PMID 26683084 DOI: 10.1016/j.brainres.2015.12.005  1
2015 Knutson DC, Clagett-Dame M. A complex RARE is required for the majority of Nedd9 embryonic expression. Transgenic Research. 24: 123-34. PMID 25120220 DOI: 10.1007/s11248-014-9825-9  1
2014 Zella JB, Plum LA, Plowchalk DR, Potochoiba M, Clagett-Dame M, Deluca HF. Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women American Journal of Nephrology. 39: 476-483. PMID 24854296 DOI: 10.1159/000362846  1
2014 Chiellini G, Grzywacz P, Plum LA, Clagett-Dame M, Deluca HF. 26-Desmethyl-2-methylene-22-ene-19-nor-1α,25-dihydroxyvitamin D 3 compounds selectively active on intestine Steroids. 83: 27-38. PMID 24513051 DOI: 10.1016/j.steroids.2014.01.012  1
2013 Marzinke MA, Mavencamp T, Duratinsky J, Clagett-Dame M. 14-3-3ε and NAV2 interact to regulate neurite outgrowth and axon elongation. Archives of Biochemistry and Biophysics. 540: 94-100. PMID 24161943 DOI: 10.1016/j.abb.2013.10.012  1
2013 Grzywacz P, Plum LA, Clagett-Dame M, Deluca HF. 26- and 27-Methyl groups of 2-substituted, 19-nor-1α,25- dihydroxylated vitamin D compounds are essential for calcium mobilization in vivo Bioorganic Chemistry. 47: 9-16. PMID 23474215 DOI: 10.1016/j.bioorg.2013.01.001  1
2012 Shearer KD, Fragoso YD, Clagett-Dame M, McCaffery PJ. Astrocytes as a regulated source of retinoic acid for the brain. Glia. 60: 1964-76. PMID 22930583 DOI: 10.1002/glia.22412  1
2012 Flores A, Sicinski RR, Grzywacz P, Thoden JB, Plum LA, Clagett-Dame M, Deluca HF. A 20 S combined with a 22 r configuration markedly increases both in vivo and in vitro biological activity of 1α,25-Dihydroxy-22-methyl-2-methylene- 19-norvitamin D 3 Journal of Medicinal Chemistry. 55: 4352-4366. PMID 22490010 DOI: 10.1021/jm300187x  1
2012 Chiellini G, Rapposelli S, Zhu J, Massarelli I, Saraceno M, Bianucci AM, Plum LA, Clagett-Dame M, Deluca HF. Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase Steroids. 77: 212-223. PMID 22133546 DOI: 10.1016/j.steroids.2011.11.007  1
2012 Marzinke MA, Clagett-Dame M. The all-trans retinoic acid (atRA)-regulated gene Calmin (Clmn) regulates cell cycle exit and neurite outgrowth in murine neuroblastoma (Neuro2a) cells. Experimental Cell Research. 318: 85-93. PMID 22001116 DOI: 10.1016/j.yexcr.2011.10.002  1
2011 Clagett-Dame M, Knutson D. Vitamin A in reproduction and development. Nutrients. 3: 385-428. PMID 22254103 DOI: 10.3390/nu3040385  1
2011 Anding AL, Nieves NJ, Abzianidze VV, Collins MD, Curley RW, Clagett-Dame M. 4-Hydroxybenzyl modification of the highly teratogenic retinoid, 4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)-1-propen-1-yl]benzoic acid (TTNPB), yields a compound that induces apoptosis in breast cancer cells and shows reduced teratogenicity. Chemical Research in Toxicology. 24: 1853-61. PMID 21939267 DOI: 10.1021/tx200174n  1
2011 McNeill EM, Klöckner-Bormann M, Roesler EC, Talton LE, Moechars D, Clagett-Dame M. Nav2 hypomorphic mutant mice are ataxic and exhibit abnormalities in cerebellar development. Developmental Biology. 353: 331-43. PMID 21419114 DOI: 10.1016/j.ydbio.2011.03.008  1
2011 Deluca HF, Bedale W, Binkley N, Gallagher JC, Bolognese M, Peacock M, Aloia J, Clagett-Dame M, Plum L. The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: Results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial Journal of Bone and Mineral Research. 26: 538-545. PMID 20890933 DOI: 10.1002/jbmr.256  1
2011 Li H, Palczewski K, Baehr W, Clagett-Dame M. Vitamin A deficiency results in meiotic failure and accumulation of undifferentiated spermatogonia in prepubertal mouse testis. Biology of Reproduction. 84: 336-41. PMID 20881313 DOI: 10.1095/biolreprod.110.086157  1
2010 Grzywacz P, Chiellini G, Plum LA, Clagett-Dame M, Deluca HF. Removal of the 26-methyl group from 19-nor-1α,25-dihydroxyvitamin D3 markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription Journal of Medicinal Chemistry. 53: 8642-8649. PMID 21105677 DOI: 10.1021/jm1010447  1
2010 Nieves NJ, Ahrens JM, Plum LA, Deluca HF, Clagett-Dame M. Identification of a unique subset of 2-methylene-19-nor analogs of vitamin D with comedolytic activity in the rhino mouse Journal of Investigative Dermatology. 130: 2359-2367. PMID 20535127 DOI: 10.1038/jid.2010.142  1
2010 McNeill EM, Roos KP, Moechars D, Clagett-Dame M. Nav2 is necessary for cranial nerve development and blood pressure regulation. Neural Development. 5: 6. PMID 20184720 DOI: 10.1186/1749-8104-5-6  1
2009 Li H, MacLean G, Cameron D, Clagett-Dame M, Petkovich M. Cyp26b1 expression in murine Sertoli cells is required to maintain male germ cells in an undifferentiated state during embryogenesis. Plos One. 4: e7501. PMID 19838304 DOI: 10.1371/journal.pone.0007501  1
2009 Barycki R, Sicinski RR, Plum LA, Grzywacz P, Clagett-Dame M, DeLuca HF. Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 (2MD) selectively eliminates bone calcium mobilization activity Bioorganic and Medicinal Chemistry. 17: 7658-7669. PMID 19819702 DOI: 10.1016/j.bmc.2009.09.047  1
2009 Li H, Clagett-Dame M. Vitamin A deficiency blocks the initiation of meiosis of germ cells in the developing rat ovary in vivo. Biology of Reproduction. 81: 996-1001. PMID 19587328 DOI: 10.1095/biolreprod.109.078808  1
2009 Plonska-Ocypa K, Sicinski RR, Plum LA, Grzywacz P, Frelek J, Clagett-Dame M, DeLuca HF. 13-Methyl-substituted des-C,D analogs of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): Synthesis and biological evaluation Bioorganic and Medicinal Chemistry. 17: 1747-1763. PMID 19167893 DOI: 10.1016/j.bmc.2008.11.082  1
2009 See AW, Clagett-Dame M. The temporal requirement for vitamin A in the developing eye: mechanism of action in optic fissure closure and new roles for the vitamin in regulating cell proliferation and adhesion in the embryonic retina. Developmental Biology. 325: 94-105. PMID 18955041 DOI: 10.1016/j.ydbio.2008.09.030  1
2008 Muley PD, McNeill EM, Marzinke MA, Knobel KM, Barr MM, Clagett-Dame M. The atRA-responsive gene neuron navigator 2 functions in neurite outgrowth and axonal elongation. Developmental Neurobiology. 68: 1441-53. PMID 18726912 DOI: 10.1002/dneu.20670  1
2008 Chiellini G, Grzywacz P, Plum LA, Barycki R, Clagett-Dame M, DeLuca HF. Synthesis and biological properties of 2-methylene-19-nor-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones--weak agonists. Bioorganic & Medicinal Chemistry. 16: 8563-73. PMID 18722130 DOI: 10.1016/j.bmc.2008.08.011  1
2008 Knutson DC, Clagett-Dame M. atRA Regulation of NEDD9, a gene involved in neurite outgrowth and cell adhesion. Archives of Biochemistry and Biophysics. 477: 163-74. PMID 18585997 DOI: 10.1016/j.abb.2008.06.005  1
2008 See AW, Kaiser ME, White JC, Clagett-Dame M. A nutritional model of late embryonic vitamin A deficiency produces defects in organogenesis at a high penetrance and reveals new roles for the vitamin in skeletal development. Developmental Biology. 316: 171-90. PMID 18321479 DOI: 10.1016/j.ydbio.2007.10.018  1
2007 Anding AL, Chapman JS, Barnett DW, Curley RW, Clagett-Dame M. The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor. Cancer Research. 67: 6270-7. PMID 17616685 DOI: 10.1158/0008-5472.CAN-07-0727  1
2007 Slatopolsky E, Finch JL, Brown AJ, Ritter CS, Mizobuchi M, Plum LA, Clagett-Dame M, Sicinski RR, DeLuca HF. Effect of 2-methylene-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism Journal of Bone and Mineral Research. 22: 686-694. PMID 17444814 DOI: 10.1359/jbmr.070202  1
2007 Thomson B, Ahrens JM, Ntambi JM, DeLuca HF, Clagett-Dame M. 2-Methylene-19-nor-1α-hydroxyvitamin D3 analogs inhibit adipocyte differentiation and PPARγ2 gene transcription Archives of Biochemistry and Biophysics. 460: 192-201. PMID 17257576 DOI: 10.1016/j.abb.2006.12.020  1
2007 DeLuca HF, Plum LA, Clagett-Dame M. Selective analogs of 1α,25-dihydroxyvitamin D3 for the study of specific functions of Vitamin D Journal of Steroid Biochemistry and Molecular Biology. 103: 263-268. PMID 17241781 DOI: 10.1016/j.jsbmb.2006.12.005  1
2007 Mershon SM, Anding AL, Chapman JS, Clagett-Dame M, Stonerock LA, Curley RW. Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs. Bioorganic & Medicinal Chemistry Letters. 17: 836-40. PMID 17112722 DOI: 10.1016/j.bmcl.2006.10.050  1
2007 Grzywacz P, Plum LA, Sicinski RR, Clagett-Dame M, DeLuca HF. Methyl substitution of the 25-hydroxy group on 2-methylene-19-nor-1α,25-dihydroxyvitamin D3 (2MD) reduces potency but allows bone selectivity Archives of Biochemistry and Biophysics. 460: 274-284. PMID 17094936 DOI: 10.1016/j.abb.2006.09.028  1
2006 Clugston RD, Klattig J, Englert C, Clagett-Dame M, Martinovic J, Benachi A, Greer JJ. Teratogen-induced, dietary and genetic models of congenital diaphragmatic hernia share a common mechanism of pathogenesis. The American Journal of Pathology. 169: 1541-9. PMID 17071579 DOI: 10.2353/ajpath.2006.060445  1
2006 Clagett-Dame M, McNeill EM, Muley PD. Role of all-trans retinoic acid in neurite outgrowth and axonal elongation. Journal of Neurobiology. 66: 739-56. PMID 16688769 DOI: 10.1002/neu.20241  1
2006 Glebocka A, Sicinski RR, Plum LA, Clagett-Dame M, DeLuca HF. New 2-alkylidene 1α,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: Synthesis and biological evaluation of 2-(3′-alkoxypropylidene) and 2-(3′-hydroxypropylidene) derivatives Journal of Medicinal Chemistry. 49: 2909-2920. PMID 16686534 DOI: 10.1021/jm051082a  1
2006 Villani MG, Appierto V, Cavadini E, Bettiga A, Prinetti A, Clagett-Dame M, Curley RW, Formelli F. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. Cancer Research. 66: 3238-47. PMID 16540676 DOI: 10.1158/0008-5472.CAN-05-3362  1
2006 Plum LA, Fitzpatrick LA, Ma X, Binkley NC, Zella JB, Clagett-Dame M, DeLuca HF. 2MD, a new anabolic agent for osteoporosis treatment Osteoporosis International. 17: 704-715. PMID 16491322 DOI: 10.1007/s00198-005-0036-3  1
2006 Walker JR, Alshafie G, Nieves N, Ahrens J, Clagett-Dame M, Abou-Issa H, Curley RW. Synthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamide. Bioorganic & Medicinal Chemistry. 14: 3038-48. PMID 16412653 DOI: 10.1016/j.bmc.2005.12.044  1
2005 Ke HZ, Qi H, Crawford DT, Simmons HA, Xu G, Li M, Plum L, Clagett-Dame M, DeLuca HF, Thompson DD, Brown TA. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 20: 1742-55. PMID 16160732 DOI: 10.1359/JBMR.050605  1
2005 Alshafie GA, Walker JR, Curley RW, Clagett-Dame M, Highland MA, Nieves NJ, Stonerock LA, Abou-Issa H. Inhibition of mammary tumor growth by a novel nontoxic retinoid: chemotherapeutic evaluation of a C-linked analog of 4-HPR-glucuronide. Anticancer Research. 25: 2391-8. PMID 16082771  1
2005 Albert DM, Plum LA, Yang W, Marcet M, Lindstrom MJ, Clagett-Dame M, DeLuca HF. Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor Vitamin D analog. The Journal of Steroid Biochemistry and Molecular Biology. 97: 165-72. PMID 16055326 DOI: 10.1016/j.jsbmb.2005.06.019  1
2005 Yamamoto M, Fujinuma M, Hirano S, Hayakawa Y, Clagett-Dame M, Zhang J, McCaffery P. Retinoic acid influences the development of the inferior olivary nucleus in the rodent. Developmental Biology. 280: 421-33. PMID 15882583 DOI: 10.1016/j.ydbio.2005.02.007  1
2005 DeLuca HF, Plum LA, Clagett-Dame M, Shevde NK, Wesley Pike J, Sicinski RR. 2-Carbon-Modified Analogs of 19-Nor-1α,25-Dihydroxyvitamin D3 Vitamin D. 2: 1543-1555. DOI: 10.1016/B978-012252687-9/50091-7  1
2004 Merrill RA, See AW, Wertheim ML, Clagett-Dame M. Crk-associated substrate (Cas) family member, NEDD9, is regulated in human neuroblastoma cells and in the embryonic hindbrain by all-trans retinoic acid. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 231: 564-75. PMID 15376324 DOI: 10.1002/dvdy.20159  1
2004 Merrill RA, Ahrens JM, Kaiser ME, Federhart KS, Poon VY, Clagett-Dame M. All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos. Biological Chemistry. 385: 605-14. PMID 15318809 DOI: 10.1515/BC.2004.075  1
2004 Plum LA, Prahl JM, Ma X, Sicinski RR, Gowlugari S, Clagett-Dame M, DeLuca HF. Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl. Proceedings of the National Academy of Sciences of the United States of America. 101: 6900-4. PMID 15118084 DOI: 10.1073/pnas.0401656101  1
2003 Goldstein JT, Dobrzyn A, Clagett-Dame M, Pike JW, DeLuca HF. Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. Archives of Biochemistry and Biophysics. 420: 185-93. PMID 14622989 DOI: 10.1016/j.abb.2003.09.034  1
2003 Chapman JS, Weiss KL, Curley RW, Highland MA, Clagett-Dame M. Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis. Archives of Biochemistry and Biophysics. 419: 234-43. PMID 14592467 DOI: 10.1016/j.abb.2003.09.001  1
2003 Kaiser ME, Merrill RA, Stein AC, Breburda E, Clagett-Dame M. Vitamin A deficiency in the late gastrula stage rat embryo results in a one to two vertebral anteriorization that extends throughout the axial skeleton. Developmental Biology. 257: 14-29. PMID 12710954 DOI: 10.1016/S0012-1606(03)00044-7  1
2002 Song J, Clagett-Dame M, Peterson RE, Hahn ME, Westler WM, Sicinski RR, DeLuca HF. A ligand for the aryl hydrocarbon receptor isolated from lung. Proceedings of the National Academy of Sciences of the United States of America. 99: 14694-9. PMID 12409613 DOI: 10.1073/pnas.232562899  1
2002 Shevde NK, Plum LA, Clagett-Dame M, Yamamoto H, Pike JW, DeLuca HF. A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation. Proceedings of the National Academy of Sciences of the United States of America. 99: 13487-91. PMID 12374862 DOI: 10.1073/pnas.202471299  1
2002 Clagett-Dame M, DeLuca HF. The role of vitamin A in mammalian reproduction and embryonic development. Annual Review of Nutrition. 22: 347-81. PMID 12055350 DOI: 10.1146/annurev.nutr.22.010402.102745E  1
2002 Merrill RA, Plum LA, Kaiser ME, Clagett-Dame M. A mammalian homolog of unc-53 is regulated by all-trans retinoic acid in neuroblastoma cells and embryos Proceedings of the National Academy of Sciences of the United States of America. 99: 3422-3427. PMID 11904404 DOI: 10.1073/pnas.052017399  1
2001 Abou-Issa H, Curley RW, Alshafie GA, Weiss KL, Clagett-Dame M, Chapman JS, Mershon SM. Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis. Anticancer Research. 21: 3839-44. PMID 11911255  1
2001 Plum LA, Parada LF, Tsoulfas P, Clagett-Dame M. Retinoic acid combined with neurotrophin-3 enhances the survival and neurite outgrowth of embryonic sympathetic neurons. Experimental Biology and Medicine (Maywood, N.J.). 226: 766-75. PMID 11520943  1
2001 Weiss KL, Alshafie G, Chapman JS, Mershon SM, Abou-Issa H, Clagett-Dame M, Curley RW. An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studies. Bioorganic & Medicinal Chemistry Letters. 11: 1583-6. PMID 11412986 DOI: 10.1016/S0960-894X(01)00230-X  1
2001 Batourina E, Gim S, Bello N, Shy M, Clagett-Dame M, Srinivas S, Costantini F, Mendelsohn C. Vitamin A controls epithelial/mesenchymal interactions through Ret expression Nature Genetics. 27: 74-78. PMID 11138002 DOI: 10.1038/83792  1
2000 White JC, Highland M, Clagett-Dame M. Abnormal development of the sinuatrial venous valve and posterior hindbrain may contribute to late fetal resorption of vitamin A-deficient rat embryos Teratology. 62: 374-384. PMID 11091359 DOI: 10.1002/1096-9926(200012)62:6<374::AID-TERA4>3.0.CO;2-5  1
2000 White JC, Highland M, Kaiser M, Clagett-Dame M. Vitamin A deficiency results in the dose-dependent acquisition of anterior character and shortening of the caudal hindbrain of the rat embryo Developmental Biology. 220: 263-284. PMID 10753515 DOI: 10.1006/dbio.2000.9635  1
1999 Rohde CM, Manatt M, Clagett-Dame M, DeLuca HF. Vitamin A antagonizes the action of vitamin D in rats. The Journal of Nutrition. 129: 2246-50. PMID 10573558  1
1999 Abou-Issa HM, Alshafie GA, Curley RW, Wong MF, Clagett-Dame M, Repa JJ, Sikri V. Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth. Anticancer Research. 19: 999-1004. PMID 10368645  1
1998 White JC, Shankar VN, Highland M, Epstein ML, Deluca HF, Clagett-Dame M. Defects in embryonic hindbrain development and fetal resorption resulting from vitamin A deficiency in the rat are prevented by feeding pharmacological levels of all-trans-retinoic acid Proceedings of the National Academy of Sciences of the United States of America. 95: 13459-13464. PMID 9811822 DOI: 10.1073/pnas.95.23.13459  1
1998 Tibaduiza EC, Fleet JC, Clagett-Dame M, Krinsky NI, Russell RM. β-apo-carotenoic acids inhibit proliferation of Estrogen Receptor (ER) positive and ER negative breast tumor cell lines Faseb Journal. 12.  1
1997 Clagett-Dame M, Plum LA. Retinoid-regulated gene expression in neural development Critical Reviews in Eukaryotic Gene Expression. 7: 299-342. PMID 9607169  1
1997 Clagett-Dame M, Repa JJ. Generating and characterizing retinoid receptors from Escherichia coli and insect cell expression systems Methods in Enzymology. 282: 13-24. PMID 9330273 DOI: 10.1016/S0076-6879(97)82092-7  1
1997 Repa JJ, Berg JA, Kaiser ME, Hanson KK, Strugnell SA, Clagett-Dame M. One-step immunoaffinity purification of recombinant human retinoic acid receptor gamma. Protein Expression and Purification. 9: 319-30. PMID 9126603 DOI: 10.1006/prep.1996.0696  1
1997 Wong MF, Repa JJ, Clagett-Dame M, Curley RW. Synthesis and receptor binding affinity of conformationally restricted retinoic acid analogues Bioorganic and Medicinal Chemistry Letters. 7: 2313-2318. DOI: 10.1016/S0960-894X(97)00420-4  1
1996 Repa JJ, Plum LA, Tadikonda PK, Clagett-Dame M. All-trans 3,4-didehydroretinoic acid equals all-trans retinoic acid in support of chick neuronal development Faseb Journal. 10: 1078-1084. PMID 8801170  1
1996 Plum LA, Clagett-Dame M. All-trans retinoic acid stimulates and maintains neurite outgrowth in nerve growth factor-supported developing chick embryonic sympathetic neurons Developmental Dynamics. 205: 52-63. PMID 8770551 DOI: 10.1002/(SICI)1097-0177(199601)205:1<52::AID-AJA5>3.0.CO;2-4  1
1996 Curley RW, Abou-Issa H, Panigot MJ, Repa JJ, Clagett-Dame M, Alshafie G. Chemopreventive activities of C-glucuronide/glycoside analogs of retinoid-o-glucuronides against breast cancer development and growth Anticancer Research. 16: 757-764. PMID 8687125  1
1995 Fairman CL, Clagett-Dame M, Lennon VA, Epstein ML. Appearance of neurons in the developing chick gut Developmental Dynamics. 204: 192-201. PMID 8589443  1
1995 Plum LA, Clagett-Dame M. 9-cis-retinoic acid selectively activates the cellular retinoic acid binding protein-II gene in human neuroblastoma cells Archives of Biochemistry and Biophysics. 319: 457-463. PMID 7786028 DOI: 10.1006/abbi.1995.1317  1
1995 Munder M, Herzberg IM, Zierold C, Moss VE, Hanson K, Clagett-Dame M, Deluca HF. Identification of the porcine intestinal accessory factor that enables DNA sequence recognition by vitamin D receptor Proceedings of the National Academy of Sciences of the United States of America. 92: 2795-2799. PMID 7708726 DOI: 10.1073/pnas.92.7.2795  1
1994 Lee HJ, Clagett-Dame M, Heideman W, Weiler MS. The effect of age on muscarinic receptor transcripts in rat brain. Neuroscience Letters. 174: 205-8. PMID 7970180 DOI: 10.1016/0304-3940(94)90022-1  1
1994 Robarge MJ, Repa JJ, Hanson KK, Seth S, Clagett-Dame M, Abou-Issa H, Curley RW. N-linked analogs of retinoid O-glucuronides: potential cancer chemopreventive/chemotherapeutic agents Bioorganic and Medicinal Chemistry Letters. 4: 2117-2122. DOI: 10.1016/S0960-894X(01)80113-X  1
1993 Repa JJ, Hanson KK, Clagett-Dame M. All-trans-retinol is a ligand for the retinoic acid receptors Proceedings of the National Academy of Sciences of the United States of America. 90: 7293-7297. PMID 8394016  1
1991 DiStefano PS, Clagett-Dame M, Chelsea DM, Loy R. Developmental regulation of human truncated nerve growth factor receptor. Annals of Neurology. 29: 13-20. PMID 1847613 DOI: 10.1002/ana.410290105  1
1990 Loy R, Heyer D, Clagett-Dame M, DiStefano PS. Localization of NGF receptors in normal and Alzheimer's basal forebrain with monoclonal antibodies against the truncated form of the receptor. Journal of Neuroscience Research. 27: 651-64. PMID 1964180 DOI: 10.1002/jnr.490270426  1
1990 Clagett-Dame M, Chung C, Chao MV, DiStefano PS. Monoclonal antibodies to the cell surface and a soluble form of the human nerve growth factor receptor. Journal of Neuroscience Research. 27: 642-50. PMID 1706784 DOI: 10.1002/jnr.490270425  1
1989 Clagett-Dame M, Schoenleber R, Chung C, McKelvy JF. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes Bba - Biomembranes. 986: 271-280. PMID 2531613 DOI: 10.1016/0005-2736(89)90477-X  1
1989 Clagett-Dame M, McKelvy JF. N-linked oligosaccharides are responsible for rat striatal dopamine D2 receptor heterogeneity Archives of Biochemistry and Biophysics. 274: 145-154. PMID 2528326 DOI: 10.1016/0003-9861(89)90425-6  1
Show low-probability matches.